Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
GlaxoSmithKline Pharmaceuticals Temettü
Temettü kriter kontrolleri 3/6
GlaxoSmithKline Pharmaceuticals 1.17% cari getiri oranına sahip temettü ödeyen bir şirkettir.
Anahtar bilgiler
1.2%
Temettü verimi
92%
Ödeme oranı
| Sektör ortalama getirisi | 0.6% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | ₹32.000 |
| Hisse başına kazanç | ₹37.78 |
| Temettü verim tahmini | 1.2% |
Son temettü güncellemeleri
Recent updates
We Think GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Can Manage Its Debt With Ease
Aug 29
The GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Aug 05Investors Appear Satisfied With GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Prospects As Shares Rocket 26%
Jun 01With EPS Growth And More, GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Makes An Interesting Case
May 05GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Popularity With Investors Is Clear
Apr 14Revenue Miss: GlaxoSmithKline Pharmaceuticals Limited Fell 5.9% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 15Is Now The Time To Put GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) On Your Watchlist?
Jan 18GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Investors Are Less Pessimistic Than Expected
Dec 28Here's Why We Think GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Might Deserve Your Attention Today
Oct 05Is GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Using Too Much Debt?
Sep 12GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Has A Pretty Healthy Balance Sheet
Mar 17Does GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Have A Healthy Balance Sheet?
Sep 02GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Seems To Use Debt Rather Sparingly
Mar 02The GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Share Price Is Up 32% And Shareholders Are Holding On
Mar 20Does GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Have A Place In Your Dividend Portfolio?
Feb 27Declining Stock and Decent Financials: Is The Market Wrong About GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)?
Feb 06What Type Of Shareholders Make Up GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Share Registry?
Jan 11
GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Shareholders Have Enjoyed A 26% Share Price Gain
Dec 06Earnings Miss: GlaxoSmithKline Pharmaceuticals Limited Missed EPS By 48% And Analysts Are Revising Their Forecasts
Nov 01Tread With Caution Around GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) 1.3% Dividend Yield
Oct 29What Kind Of Shareholders Hold The Majority In GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Shares?
Sep 29If You Had Bought GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Stock A Year Ago, You Could Pocket A 30% Gain Today
Aug 30Is GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Recent Performancer Underpinned By Weak Financials?
Aug 02It Might Not Be A Great Idea To Buy GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) For Its Next Dividend
Jul 12Is GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) At Risk Of Cutting Its Dividend?
Jul 07Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: GLAXO şirketinin temettü ödemeleri son 10 yıldır dalgalı seyretti.
Büyüyen Temettü: GLAXO şirketinin temettü ödemeleri son 10 yıldır artış göstermektedir.
Piyasaya Karşı Temettü Getirisi
| GlaxoSmithKline Pharmaceuticals Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (GLAXO) | 1.2% |
| Pazarın Alt %25'i (IN) | 0.2% |
| Pazarın En İyi %25'i (IN) | 1.1% |
| Sektör Ortalaması (Pharmaceuticals) | 0.6% |
| Analist tahmini (GLAXO) (3 yıla kadar) | 1.2% |
Önemli Temettü: GLAXO 'in temettüsü ( 1.17% ), Indian piyasasındaki temettü ödeyenlerin en alttaki %25'inden ( 0.24% ) daha yüksektir.
Yüksek Temettü: GLAXO 'in temettüsü ( 1.17% ) Indian pazarındaki temettü ödeyenlerin en üst %25'indedir ( 1.03% )
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Yüksek ödeme oranı ( 91.9% ) nedeniyle GLAXO 'un temettü ödemeleri kazançlar tarafından yeterince karşılanmıyor.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Yüksek nakit ödeme oranı ( 98.4% ) nedeniyle, GLAXO 'un temettü ödemeleri nakit akışları tarafından yeterince karşılanmıyor.